These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 27479745)

  • 41. Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III.
    Terra AP; Murta EF; Maluf PJ; Caballero OL; Brait M; Adad SJ
    Tumori; 2007; 93(6):572-9. PubMed ID: 18338492
    [TBL] [Abstract][Full Text] [Related]  

  • 42. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.
    Murphy N; Ring M; Killalea AG; Uhlmann V; O'Donovan M; Mulcahy F; Turner M; McGuinness E; Griffin M; Martin C; Sheils O; O'Leary JJ
    J Clin Pathol; 2003 Jan; 56(1):56-63. PubMed ID: 12499437
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunostaining of p16(INK4a)/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases.
    Byun SW; Lee A; Kim S; Choi YJ; Lee YS; Park JS
    Int J Med Sci; 2013; 10(12):1602-7. PubMed ID: 24151431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. p16 INK4a and Ki67 expression in normal, dysplastic and neoplastic uterine cervical epithelium and human papillomavirus (HPV) infection.
    Calil LN; Edelweiss MI; Meurer L; Igansi CN; Bozzetti MC
    Pathol Res Pract; 2014 Aug; 210(8):482-7. PubMed ID: 24793773
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Candidate HPV genotypes not included in the 9-valent vaccine for prevention of CIN 2-3.
    Gonzalez-Bosquet E; Gibert M; Serra M; Hernandez-Saborit A; Gonzalez-Fernandez A
    Int J Gynecol Cancer; 2020 Jul; 30(7):954-958. PubMed ID: 32467333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of p16(INK4a) in relation to histopathology and viral load of 'high-risk' HPV types in cervical neoplastic lesions.
    Andersson S; Wangsa D; Flores-Staino C; Safari H; Mints M; Hjerpe A; Hagmar B; Johansson B
    Eur J Cancer; 2006 Nov; 42(16):2815-20. PubMed ID: 16973350
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer.
    Branca M; Giorgi C; Santini D; Di Bonito L; Ciotti M; Costa S; Benedetto A; Casolati EA; Favalli C; Paba P; Di Bonito P; Mariani L; Syrjänen S; Bonifacio D; Accardi L; Zanconati F; Syrjänen K;
    Am J Clin Pathol; 2005 Jul; 124(1):113-21. PubMed ID: 15923164
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cervical Intraepithelial Neoplasia 3 (Cervical Intraepithelial Neoplasia 3/High-Grade Squamous Intraepithelial Lesion) in Human Papillomavirus-Vaccinated Women-Results From a Tertiary Referral Center.
    Domröse CM; Wieland U; Pilch H; Einzmann T; Schömig-Markiefka B; Mallmann P; Silling S; Mallmann MR
    J Low Genit Tract Dis; 2022 Apr; 26(2):122-126. PubMed ID: 35019900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types.
    Agoff SN; Lin P; Morihara J; Mao C; Kiviat NB; Koutsky LA
    Mod Pathol; 2003 Jul; 16(7):665-73. PubMed ID: 12861062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic utility of p16INK4a: a reappraisal of its use in cervical biopsies.
    Mulvany NJ; Allen DG; Wilson SM
    Pathology; 2008 Jun; 40(4):335-44. PubMed ID: 18446622
    [TBL] [Abstract][Full Text] [Related]  

  • 51. p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer.
    Murphy N; Ring M; Heffron CC; King B; Killalea AG; Hughes C; Martin CM; McGuinness E; Sheils O; O'Leary JJ
    J Clin Pathol; 2005 May; 58(5):525-34. PubMed ID: 15858126
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of HPV subtypes not covered by the nine-valent vaccine in patients with CIN 2-3 and cervical squamous cell carcinoma.
    Ma MJ; Wang YN; Zhu JF; Wang XY; Jin YB; Liu XN; Wu SF; Yang YB
    Curr Probl Cancer; 2021 Dec; 45(6):100761. PubMed ID: 34154817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comprehensive analysis of 130 multicentric intraepithelial female lower genital tract lesions by HPV typing and p16 expression profile.
    Hampl M; Wentzensen N; Vinokurova S; von Knebel-Doeberitz M; Poremba C; Bender HG; Kueppers V
    J Cancer Res Clin Oncol; 2007 Apr; 133(4):235-45. PubMed ID: 17294241
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HPV genotyping and p16 expression in Xingu Indigenous Park, Brazil.
    Freitas VG; Focchi GR; Pereira ER; Levi JE; Speck NM; Ribalta JC
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706717
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer.
    Branca M; Giorgi C; Santini D; Di Bonito L; Ciotti M; Benedetto A; Paba P; Costa S; Bonifacio D; Di Bonito P; Accardi L; Favalli C; Syrjänen K;
    J Clin Pathol; 2006 Jan; 59(1):40-7. PubMed ID: 16394279
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.
    Carozzi F; Confortini M; Dalla Palma P; Del Mistro A; Gillio-Tos A; De Marco L; Giorgi-Rossi P; Pontenani G; Rosso S; Sani C; Sintoni C; Segnan N; Zorzi M; Cuzick J; Rizzolo R; Ronco G;
    Lancet Oncol; 2008 Oct; 9(10):937-45. PubMed ID: 18783988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri.
    Klaes R; Friedrich T; Spitkovsky D; Ridder R; Rudy W; Petry U; Dallenbach-Hellweg G; Schmidt D; von Knebel Doeberitz M
    Int J Cancer; 2001 Apr; 92(2):276-84. PubMed ID: 11291057
    [TBL] [Abstract][Full Text] [Related]  

  • 58. p16(INK4a) immunostaining as an alternative to histology review for reliable grading of cervical intraepithelial lesions.
    Dijkstra MG; Heideman DA; de Roy SC; Rozendaal L; Berkhof J; van Krimpen K; van Groningen K; Snijders PJ; Meijer CJ; van Kemenade FJ
    J Clin Pathol; 2010 Nov; 63(11):972-7. PubMed ID: 20924035
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
    Song F; Yan P; Huang X; Wang C; Du H; Qu X; Wu R
    BMC Cancer; 2022 Jan; 22(1):42. PubMed ID: 34991494
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions.
    Bais AG; Beckmann I; Lindemans J; Ewing PC; Meijer CJ; Snijders PJ; Helmerhorst TJ
    J Clin Pathol; 2005 Oct; 58(10):1096-100. PubMed ID: 16189158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.